DHR vs VST: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and Vistra Corp. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
Danaher Corporation Β· Healthcare
$221.12
+29.6% upside to fair value
Med Conviction Grade B High Quality
VS
Vistra Corp. Β· Utilities
$140.67
-23.0% upside to fair value
Med Conviction Grade C
QuantHub Verdict
DHR has more upside to fair value (+29.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DHR VST
Current Price $221.12 $140.67
Fair Value Estimate $286.52 $108.27
Upside to Fair Value +29.6% -23.0%
Market Cap $155.4B $47.4B
Forward P/E β€” β€”
EV / EBITDA 24.8x 10.3x
Price / Sales 6.2x 3.0x
Price / FCF 28.5x 34.7x
Revenue Growth YoY +5.5% -5.5%
Gross Margin 58.5% 13.0%
Operating Margin 20.4% 2.3%
Return on Equity 7.7% 41.5%
Dividend Yield 0.65% 0.65%
FCF Yield 3.51% 2.88%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR β€” Danaher Corporation
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
VST β€” Vistra Corp.
Vistra Corp. is a vertically integrated independent power producer and retail electricity supplier operating roughly 38,700 megawatts of generation across natural gas, nuclear, coal, solar, and battery storage, serving about 4.3 million retail customers in 20 states and the District of Columbia. The business quality is mixed: the diversified PJM and ERCOT fleet plus retail load is a genuine struc…
Accumulation Zones
Metric DHR VST
Zone Low $214.89 $81.20
Zone High $243.54 $92.03
In Buy Zone? Yes No
← DHR Research    VST Research β†’    All Research